Method for analysis of nanoparticle hemolytic properties in vitro

Nano Letters

Volumn 8, Issue 8, 2008, Pages 2180-2187

  Dobrovolskaia, Marina A ^a   Clogston, Jeffrey D ^a   Neun, Barry W ^a   Hall, Jennifer B ^a   Patri, Anil K ^a   McNeil, Scott E ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE METHODS; BLOOD COMPONENTS; DRUG CARRIERS; IN-VITRO; IN-VITRO ASSAYS; IN-VITRO EVALUATIONS; IN-VITRO TESTS; IN-VIVO; PATHOLOGICAL CONDITIONS; PHYSICO-CHEMICAL PROPERTIES; PRECLINICAL DEVELOPMENT; RED BLOOD CELLS; SMALL SIZES; SMALL-MOLECULE DRUGS;

BIOCOMPATIBILITY; BLOOD; DRUG PRODUCTS;

NANOPARTICLES;

NANOPARTICLE; POLYLYSINE;

ARTICLE; CHEMISTRY; DRUG EFFECT; HEMOLYSIS; HUMAN;

HEMOLYSIS; HUMANS; NANOPARTICLES; POLYLYSINE;

EID: 52049097752     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl0805615     Document Type: Article

References (39)

1. McNeil, S. E. J. Leukocyte Biol. 2005, 78 (3), 585-594.
2. Ferrari, M.; Downing, G. BioDrugs 2005, 19 (4), 203-210.
3. http://www.fda.gov/nanotechnology/.
4. http://ncl.cancer.gov.
5. http://www.astm.org(technical committee E56).
6. http://www.iso.org(technical committee TC229).
7. Brownlie, A.; Uchegbu, I. F.; Schatzlein, A. G. Int. J. Pharm. 2004, 274 (1-2), 41-52.
8. Cheng, F. Y.; Su, C. H.; Yang, Y. S.; Yeh, C. S.; Tsai, C. Y.; Wu, C. L.; Wu, M. T.; Shieh, D. B. Biomaterials 2005, 26 (7), 729-738.
9. Chouly, C; Bordenave, L.; Bareille, R.; Guerin, V.; Baquey, A.; Pouliquen, D.; Baquey, C.; Jallet, P. Clin. Mater. 1994, 75 (4), 293-301.
10. Duguid, J. G.; Li, C.; Shi, M.; Logan, M. J.; Alila, H.; Rolland, A.; Tomlinson, E.; Sparrow, J. T.; Smith, L. C. Biophys. J. 1998, 74 (6), 2802-2814.
11. Dutta, T.; Agashe, H. B.; Garg, M.; Balasubramanium, P.; Kabra, M.; Jain, N. K. J. Drug Targeting 2007, 15 (1), 89-98.
12. Foger, F.; Noonpakdee, W.; Loretz, B.; Joojuntr, S.; Salvenmoser, W.; Thaler, M.; Bernkop-Schnurch, A. Int. J. Pharm. 2006, 319 (1-2), 139-146.
13. Goodman, C. M.; McCusker, C. D.; Yilmaz, T.; Rotello, V. M. Bioconjugate Chem. 2004, 15 (4), 897-900.
14. Guowei, D.; Adriane, K.; Chen, X.; Jie, C.; Yinfeng, L. Int. J. Pharm. 2007, 328 (1), 78-85.
15. Jin, Y.; Tong, L.; Ai, P.; Li, M.; Hou, X. Int. J. Pharm. 2006, 309 (1-2), 199-207.
16. Kainthan, R. K.; Gnanamani, M.; Ganguli, M.; Ghosh, T.; Brooks, D. E.; Maiti, S.; Kizhakkedathu, J. N. Biomaterials 2006, 27 (31), 5377-5390.
17. Kim, D.; El-Shall, H.; Dennis, D.; Morey, T. Colloids Surf., B 2005, 40 (2), 83-91.
18. Koziara, J. M.; Oh, J. J.; Akers, W. S.; Ferraris, S. P.; Mumper, R. J. Pharm. Res. 2005, 22 (11), 1821-1828.
19. Lim, S. J.; Lee, M. K.; Kim, C. K. J. Controlled Release 2004, 100 (1), 53-61.
20. Nimesh, S.; Goyal, A.; Pawar, V.; Jayaraman, S.; Kumar, P.; Chandra, R.; Singh, Y.; Gupta, K. C. J. Controlled Release 2006, 110 (2), 457-468.
21. Puzyr, A. P.; Neshumaev, D. A.; Tarskikh, S. V.; Makarskaia, G. V.; Dolmatov, V.; Bondar, V. S. Biofizika 2005, 50 (1), 101-106.
22. Schubert, M. A.; Muller-Goymann, C. C. Eur. J. Pharm. Biopharm. 2005, 61 (1-2), 77-86.
23. Verma, A. K.; Sachin, K.; Saxena, A.; Bohidar, H. B. Curr. Pharm. Biotechnol. 2005, 6 (2), 121-130.
24. Vittaz, M.; Bazile, D.; Spenlehauer, G.; Verrecchia, T.; Veillard, M.; Puisieux, F.; Labarre, D. Biomaterials 1996, 17 (16), 1575-1581.
25. Zobel, H. P.; Stieneker, F.; Atmaca-Abdel Aziz, S.; Gilbert, M.; Werner, D.; Noe, C. R.; Kreuter, J.; Zimmer, A. Eur. J. Pharm. Biopharm. 1999, 48 (1), 1-12.
26. Standard practice for assessment of hemolytic properties of materials; ASTM International: West Conshohocken, PA, 2000.
27. DeSilva, B.; Smith, W.; Weiner, R.; Kelley, M.; Smolec, J.; Lee, B.; Khan, M.; Tacey, R.; Hill, H.; Celniker, A. Pharm. Res. 2003, 20 (11), 1885-1900.
28. http://ncl.cancer.gov/NCL-Method-ITA-1.pdf.
29. www.fda.gov/cber/summaries/120600bio10.ppt.
30. Smolec, J.; DeSilva, B.; Smith, W.; Weiner, R.; Kelly, M.; Lee, B.; Khan, M.; Tacey, R.; Hill, H.; Celniker, A.; Shah, V.; Bowsher, R.; Mire-Sluis, A.; Findlay, J. W.; Saltarelli, M.; Quarmby, V.; Lansky, D.; Dillard, R.; Ullmann, M.; Keller, S.; Karnes, H. T. Pharm. Res. 2005, 22 (9), 1425-1431.
31. Dobrovolskaia, M. A.; McNeil, S. E. Nat. Nanotechnol. 2007, 2 (8), 469-478.
32. Lewin, S. N.; Mutch, D. G.; Whitcomb, B. P.; Liapis, H.; Herzog, T. J. Gynecol. Oncol. 2005, 97 (1), 228-233.
33. Rivera, E.; Valero, V.; Aran, B.; Royce, M.; Adinin, R.; Hoelzer, K.; Walters, R.; Wade, J. L., 3rd; Pusztai, L.; Hortobagyi, G. N. J. Clin. Oncol. 2003, 21 (17), 3249-3254.
34. Chen, H.; Zhang, Z.; Almarsson, O.; Marier, J. F.; Berkovitz, D.; Gardner, C. R. Pharm. Res. 2005, 22 (3), 356-361.
35. Murphy, P. G.; Davies, M. J.; Columb, M. O.; Stratford, N. Br. J. Anaesth. 1996, 76 (4), 536-543.
36. Amin, K.; Dannenfelser, R. M. J. Pharm. Sci. 2006, 95 (6), 1173-1176.
37. Krzyzaniak, J. F.; Raymond, D. M.; Yalkowsky, S. H. PDA J. Pharm. Sci. Technol. 1996, 50 (4), 223-226.
38. Krzyzaniak, J. F.; Alvarez Nunez, F. A.; Raymond, D. M.; Yalkowsky, S. H. J. Pharm. Sci. 1997, 86 (11), 1215-7.
39. Krzyzaniak, J. F.; Yalkowsky, S. H. PDA J. Pharm. Sci. Technol. 1998, 52 (2), 66-69.